|
|
||||||||
Departments of Psychiatry and Diagnostic Radiology, Yale University School of Medicine, New Haven, Connecticut and West Haven VA Medical Center, West Haven, Connecticut
Correspondence: For correspondence and reprints contact: Anissa Abi-Dargham, MD, Department of Psychiatry, Yale University and West Haven VA Medical Center/116A2, 950 Campbell Avenue, West Haven, CT 06516.
ABSTRACT
Iodine-123-iomazenil is a SPECT radiotracer used to image and quantify benzodiazepine receptors. The reproducibility of the measurement of benzodiazepine receptors in human brain with [123I]iomazenil and SPECT was investigated with a test/retest paradigm. Methods: Six subjects underwent two experiments during a 1-wk interval, Iodine-123-iomazenil was injected as a single bolus (12 mCi). The time-activity curves of the tracer in the arterial plasma were measured and corrected for metabolites. Regional time-activity curves of five brain regions were measured with the CERASPECT camera for 145 min postinjection with serial 2-min acquisitions. Data were analyzed using three kinetic models that included a two-compartment model, an unconstrained three-compartment model and a three-compartment model with a constraint on the nondisplaceable compartment. Results: The results from the various analyses and fitting strategies were compared. The variability (average absolute difference between test and retest, expressed as a percentage of the mean of both measurements) was 10% to 17%, depending on the outcome measure and the fitting procedure. The most reproducible outcome measure was the regional tracer distribution volume relative to the total arterial concentration (VT'). VT' showed an average regional variability of 10% ± 2%, with an intraclass correlation coefficient of 0.81. Conclusion: SPECT measurement of regional [123I]iomazenil VT' is reproducible and reliable. The use of regional ratios results in a significant loss of information.
Key Words: SPECT iodine-123-iomazenil reproducibility benzodiazepine receptor
This article has been cited by other articles:
![]() |
J. H. Krystal, J. Staley, G. Mason, I. L. Petrakis, J. Kaufman, R. A. Harris, J. Gelernter, and J. Lappalainen {gamma}-Aminobutyric Acid Type A Receptors and Alcoholism: Intoxication, Dependence, Vulnerability, and Treatment. Arch Gen Psychiatry, September 1, 2006; 63(9): 957 - 968. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Millet, C. Graf, M. Moulin, and V. Ibanez SPECT Quantification of Benzodiazepine Receptor Concentration Using a Dual-Ligand Approach J. Nucl. Med., May 1, 2006; 47(5): 783 - 792. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Staley, C. H. van Dyck, D. Weinzimmer, E. Brenner, R. M. Baldwin, G. D. Tamagnan, P. Riccardi, E. Mitsis, and J. P. Seibyl 123I-5-IA-85380 SPECT Measurement of Nicotinic Acetylcholine Receptors in Human Brain by the Constant Infusion Paradigm: Feasibility and Reproducibility J. Nucl. Med., September 1, 2005; 46(9): 1466 - 1472. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Catafau, V. Perez, M. M. Penengo, S. Bullich, M. Danus, D. Puigdemont, J. C. Pascual, I. Corripio, J. Llop, J. Perich, et al. SPECT of Serotonin Transporters Using 123I-ADAM: Optimal Imaging Time After Bolus Injection and Long-Term Test-Retest in Healthy Volunteers J. Nucl. Med., August 1, 2005; 46(8): 1301 - 1309. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Staley, C. Gottschalk, I. L. Petrakis, R. Gueorguieva, S. O'Malley, R. Baldwin, P. Jatlow, N. P. L. G. Verhoeff, E. Perry, D. Weinzimmer, et al. Cortical {gamma}-Aminobutyric Acid Type A-Benzodiazepine Receptors in Recovery From Alcohol Dependence: Relationship to Features of Alcohol Dependence and Cigarette Smoking Arch Gen Psychiatry, August 1, 2005; 62(8): 877 - 888. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Bremner, R. B. Innis, S. M. Southwick, L. Staib, S. Zoghbi, and D. S. Charney Decreased Benzodiazepine Receptor Binding in Prefrontal Cortex in Combat-Related Posttraumatic Stress Disorder Am J Psychiatry, July 1, 2000; 157(7): 1120 - 1126. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |